Patents by Inventor Sally Schroeter

Sally Schroeter has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20120282248
    Abstract: The invention provides improved agents and methods for treatment of cerebral amyloid angiopathy (CAA) and methods to effect prophylaxis of CAA. The methods can treat CAA concurrently with Alzheimer's disease or separately. The methods can effect prophylaxis of CAA concurrently with Alzheimer's disease or separately. The methods involve administering antibody that is specific for the N-terminus of A? or an agent that can induce such an antibody.
    Type: Application
    Filed: March 30, 2011
    Publication date: November 8, 2012
    Applicants: Wyeth LLC, Janssen Alzheimer Immunotherapy
    Inventors: Sally Schroeter, Kate Dora Games, Wagner Zago
  • Patent number: 8003097
    Abstract: The invention provides improved agents and methods for treatment of cerebral amyloid angiopathy (CAA) and methods to effect prophylaxis of CAA. The methods can treat CAA concurrently with Alzheimer's disease or separately. The methods can effect prophylaxis of CAA concurrently with Alzheimer's disease or separately. The methods involve administering antibody that is specific for the N-terminus of A? or an agent that can induce such an antibody.
    Type: Grant
    Filed: July 28, 2008
    Date of Patent: August 23, 2011
    Assignees: Janssen Alzheimer Immunotherapy, Wyeth LLC
    Inventors: Sally Schroeter, Kate Dora Games, Wagner Zago
  • Publication number: 20090142270
    Abstract: The invention provides improved agents and methods for treatment of cerebral amyloid angiopathy (CAA) and methods to effect prophylaxis of CAA. The methods can treat CAA concurrently with Alzheimer's disease or separately. The methods can effect prophylaxis of CAA concurrently with Alzheimer's disease or separately. The methods involve administering antibody that is specific for the N-terminus of A? or an agent that can induce such an antibody.
    Type: Application
    Filed: July 28, 2008
    Publication date: June 4, 2009
    Applicant: Elan Pharma International Limited
    Inventors: Sally Schroeter, Kate Dora Games, Wagner Zago
  • Publication number: 20080292625
    Abstract: The invention provides improved agents and methods for treatment of cerebral amyloid angiopathy (CAA) and methods to effect prophylaxis of CAA. The methods can treat CAA concurrently with Alzheimer's disease or separately. The methods can effect prophylaxis of CAA concurrently with Alzheimer's disease or separately. The methods involve administering antibody that is specific for the N-terminus of A? or an agent that can induce such an antibody.
    Type: Application
    Filed: April 18, 2008
    Publication date: November 27, 2008
    Inventors: Sally Schroeter, Kate Dora Games